gw-0742

GW 5074

HY-10542 100mg
EUR 323

GW 766994

HY-107051 25mg
EUR 1772

GW 501516

HY-10838 5mg
EUR 119

GW-406381

HY-119304 1mg
EUR 160

GW 6471

HY-15372 50mg
EUR 1061

GW 441756

HY-18314 50mg
EUR 628

GW 4064

HY-50108 200mg
EUR 1221

GW-1100

HY-50691 50mg
EUR 695

GW Antibody

20-abx121490
  • EUR 300.00
  • EUR 439.00
  • EUR 189.00
  • 100 ul
  • 200 ul
  • 30 ul

GW 441756

20-abx076646
  • EUR 384.00
  • EUR 1052.00
  • 10 mg
  • 50 mg

GW-1100

A3452-10 10 mg
EUR 203
Description: GW1100 is a selective GPR40 antagonist.

GW-1100

A3452-25 25 mg
EUR 373
Description: GW1100 is a selective GPR40 antagonist.

GW-1100

A3452-5 5 mg
EUR 131
Description: GW1100 is a selective GPR40 antagonist.

GW-1100

A3452-50 50 mg
EUR 656
Description: GW1100 is a selective GPR40 antagonist.

GW 610

B6072-10 10 mg
EUR 239
Description: GI50: < 0.1 nM for MCF-7 and MDA 468 cancer cell linesGW 610 is a potent antiproliferative agent with tyrosine kinase inhibitory properties.

GW 610

B6072-5 5 mg
EUR 157
Description: GI50: < 0.1 nM for MCF-7 and MDA 468 cancer cell linesGW 610 is a potent antiproliferative agent with tyrosine kinase inhibitory properties.

GW 610

B6072-50 50 mg
EUR 877
Description: GI50: < 0.1 nM for MCF-7 and MDA 468 cancer cell linesGW 610 is a potent antiproliferative agent with tyrosine kinase inhibitory properties.

GW 803430

B7625-10 10 mg
EUR 293

GW 803430

B7625-25 25 mg
EUR 598

GW 803430

B7625-5 5 mg
EUR 183

GW 542573X

B7643-10 10 mg
EUR 366

GW 542573X

B7643-50 50 mg
EUR 1379

GW 627368

B7696-10 10 mg
EUR 464

GW 627368

B7696-50 50 mg
EUR 1795

GW 6471

B7797-10 10 mg
EUR 318
Description: PPAR? antagonist (IC50 = 0.24 ?M). Enhances the binding affinity of the PPAR? ligand-binding domain to the co-repressor proteins SMRT and NCoR.

GW 6471

B7797-25 25 mg
EUR 659
Description: PPAR? antagonist (IC50 = 0.24 ?M). Enhances the binding affinity of the PPAR? ligand-binding domain to the co-repressor proteins SMRT and NCoR.

GW 6471

B7797-5 5 mg
EUR 221
Description: PPAR? antagonist (IC50 = 0.24 ?M). Enhances the binding affinity of the PPAR? ligand-binding domain to the co-repressor proteins SMRT and NCoR.

GW 590735

C4916-1 1 mg
EUR 109

GW 590735

C4916-10 10 mg
EUR 528

GW 590735

C4916-25 25 mg
EUR 1098

GW 590735

C4916-5 5 mg
EUR 319

GW 7647

B6826-10 10 mg
EUR 283

GW 7647

B6826-25 25 mg
EUR 487

GW 7647

B6826-5 5 mg
EUR 206

GW-441756

B1147-25
EUR 631

GW-441756

B1147-5
EUR 196

GW-4064

B2278-25
EUR 501

GW-4064

B2278-5
EUR 164

GW-311616A

B2559-1
EUR 142

GW-311616A

B2559-5
EUR 414

GW-6471

9453-1
EUR 131

GW-6471

9453-5
EUR 370

GW-7647

9571-25
EUR 675

GW-7647

9571-5
EUR 207

GW 9662

1697-5
EUR 142

GW-786034

1916-25
EUR 305

GW-786034

1916-5
EUR 126

GW-5074

2412-25
EUR 544

GW-5074

2412-5
EUR 175

GW 9508

2817-10
EUR 196

GW 9508

2817-50
EUR 631

pGADT7- GW

PVT11253 2 ug
EUR 301

pGBKT7- GW

PVT11255 2 ug
EUR 301

GW 791343 hydrochloride

E1KS2242 10mg
EUR 1541

GW Blocking Peptide

20-abx162574
  • EUR 272.00
  • EUR 411.00
  • 1 mg
  • 5 mg

Pazopanib (GW-786034)

A3022-100 100 mg
EUR 224
Description: Pazopanib is a potent and selective second generation multi-targeted receptor tyrosine kinase inhibitor of vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR) and c-kit tyrosine kinases.

Pazopanib (GW-786034)

A3022-25 25 mg
EUR 108
Description: Pazopanib is a potent and selective second generation multi-targeted receptor tyrosine kinase inhibitor of vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR) and c-kit tyrosine kinases.

Pazopanib (GW-786034)

A3022-5.1 10 mM (in 1mL DMSO)
EUR 113
Description: Pazopanib is a potent and selective second generation multi-targeted receptor tyrosine kinase inhibitor of vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR) and c-kit tyrosine kinases.

Pazopanib (GW-786034)

A3022-500 500 mg
EUR 606
Description: Pazopanib is a potent and selective second generation multi-targeted receptor tyrosine kinase inhibitor of vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR) and c-kit tyrosine kinases.

Pazopanib (GW-786034)

A3022-S Evaluation Sample
EUR 81
Description: Pazopanib is a potent and selective second generation multi-targeted receptor tyrosine kinase inhibitor of vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR) and c-kit tyrosine kinases.